IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
Content includes: - Market Data - Interviews and Analysis - Special Features (Market Forecasts, M&A Analysis, Executive Compensation Table, Surveys, etc.) - Company Financial Results - Product Developments - Regional and Industry Opportunities
Page Count: 50
Table of Contents
At-line Analysis for Bioprocess Development Takes a Step Forward
Improvements in the IVD Market
Major Trends
Top IVD Companies
Executive Briefing
10x Genomics IPO Brings in Over $357 Million
KKR Weighs LGC Sale
10x Wins Stay of Injunction as Bio-Rad Files New Suit
Cell Culture Media Supplier Acquired
Second Quarter Results: Bio-Rad Laboratories, Bio-Techne, Hitachi High-Technologies, QIAGEN and Tecan
Bio-Rad Laboratories’ Droplet Digital PCR Products and Others Offset Declining Process Chromatography Sales
Bio-Techne Achieves Full-Year Double-Digit Sales Growth for the First Time
Q4 & FYE
Hitachi High-Technologies Announces Results for the New Analytical & Medical Solutions and Nano-Technology Reporting Segments
Restructuring of QIAGEN’s NGS Joint Venture in China Impacts Full-Year Sales Guidance
Life Sciences’ North American Sales Help Drive First-Half Tecan Revenue
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…